Skip to content
Menu

COSMOS Pharmaceutical Corporation CSMYF

Full chart Compare
Set alert

Price alert · CSMYF

All alert types
39.89 USD 0.00 (+0.00%)

Regular-session close

39.89 Day range 39.89
37.06 52-week range 48.27
YTD
-17.36%
1 year
-13.40%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

3.65 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 14.6×
P/S 0.4×
P/B 1.6×
P/FCF -40.1×
EV/EBITDA 7.2×
EV/Sales 0.4×
FCF Yield -2.5%

Profitability

Gross Margin 20.9%
Operating Margin 3.9%
Net Margin 2.9%
ROE 11.3%
ROIC 8.4%
ROA 5.4%

Growth (YoY)

Revenue 8.8%
Operating Income 4.9%
EPS (diluted) 3.6%
Free Cash Flow -1260.1%

Financial Health

Current Ratio 0.8×
Quick Ratio 0.4×
Debt / Equity 0.3×
Net Debt / EBITDA 0.3×
Interest Coverage 72.9×

Dividends

Dividend Yield 1.3%
Payout Ratio 18.5%

Annual · latest fiscal year ends 2026-05-31